KLA318-2 Nanocrystal Injection: Clinical Trials

1 trial of KLA318-2 Nanocrystal Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow KLA318-2 Nanocrystal Injection: new trials by email Literature Review of KLA318-2 Nanocrystal Injection trials Research Report on KLA318-2 Nanocrystal Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Study of KLA318-2 Nanocrystal Injection
KLA318-2 Nanocrystal Injection, Celebrex Capsule - Healthy Participants
Phase 1RecruitingHunan Kelun Pharmaceutical Co., Ltd.482025-09-012026-05-26

Sponsors

Hunan Kelun Pharmaceutical Co., Ltd. (1)

Countries

China (1)